Images in Pediatric Neurosurgery
A Case of Metachronous Single Metastasis of Medulloblastoma to the Lateral Ventricle: De novo Lesion or Metastasis due to Reversed Cerebrospinal Fluid Flow following Ventriculoperitoneal Shunt?Singh A.a · Garg R.a · Gupta K.b · Salunke P.a
Departments of aNeurosurgery and bHistopathology, PGIMER, Chandigarh, India
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
- Warmuth-Metz M, Blashofer S, von Bueren AO, von Hoff K, Bison B, Pohl F, Kortmann RD, Pietsch T, Rutkowski S: Recurrence in childhood medulloblastoma. J Neurooncol 2011;103:705-711.
- Tabori U, Baskin B, Shago M, Alon N, Taylor MD, Ray PN, Bouffet E, Malkin D, Hawkins C: Universal poor survival in children with medulloblastoma harbouring somatic TP53 mutations. J Clin Oncol 2010;28:1345-1350.
- Sure U, Bertalanffy H, Isenmann S, Brandner S, Berghorn WJ, Seeger W, Aguzzi A: Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients. Acta Neurochir (Wien) 1995;136:117-126.
- Rollins N, Mendelsohn D, Mulne A, Barton R, Diehl J, Reyes N, Sklar F: Recurrent medulloblastoma: frequency of tumor enhancement on Gd-DTPA MR imaging. AJR Am J Roentgenol 1990;155:153-157.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.